COVID-19 inflammatory signature in a Mozambican cohort: unchanged red blood series and reduced levels of IL-6 and other proinflammatory cytokines
The lack of variation in red and platelet series, coupled with a decrease in the levels of classical pro-inflammatory in severe cases, deviates from what has been reported in other contexts suggesting, that there may be peculiarities in COVID-19 manifestation within the context of this study population. Furthermore, these results identify parameters with potential for clinical management of COVID-19 and therefore good resource allocation, particularly for severe cases.
Authors
- Vânia Maphossa
- Igor Paulo Ubisse Capitine (ORCID: https://orcid.org/0000-0003-2346-2745)
- Eugênia Terra‐Granado (ORCID: https://orcid.org/0000-0002-3616-140X)
- Lúcia Chambal (ORCID: https://orcid.org/0000-0002-2580-2494)
- Celso Castiano (ORCID: https://orcid.org/0009-0008-4194-3909)
- Osvaldo Inlamea (ORCID: https://orcid.org/0000-0003-3930-7432)
- Raquel Matavele Chissumba (ORCID: https://orcid.org/0000-0003-1957-340X)
- Jahit Sacarlal (ORCID: https://orcid.org/0000-0003-1059-217X)
- Onélia Guiliche
- Almiro Tivane (ORCID: https://orcid.org/0000-0002-8308-4136)
- Teresa Babetine
- Marino Marengue
Institutions
- Eduardo Mondlane University (MZ)
- Maputo Central Hospital (MZ)
- Instituto Nacional de Saúde (MZ)
- Instituto Nacional de Câncer - INCA (BR)
- Instituto de Investigação Agrária de Moçambique (MZ)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1186/s12879-024-10132-6
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Organization for Women in Science for the Developing World